AIM Vaccine Announces Proposed Listing on the Main Board of SEHK Sep 23, 2022 17:06 HKT/SGT Read More
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022 Sep 22, 2022 14:13 HKT/SGT Read More
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah Sep 21, 2022 19:00 HKT/SGT Read More
Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia Conference Sep 15, 2022 17:00 HKT/SGT Read More
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines Sep 13, 2022 06:40 HKT/SGT Read More
Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma Sep 12, 2022 14:37 HKT/SGT Read More
エーザイと Merck、切除不能な肝細胞がんを対象として「レンビマ」と「キイトルーダ」との併用療法と「レンビマ」単剤療法を比較評価した臨床第III相 LEAP-002 試験の結果を発表 Sep 12, 2022 09:00 JST Read More
Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022 Sep 12, 2022 08:00 HKT/SGT Read More